1 Varicella Attenuated Live Vaccine Market Overview 1.1 Varicella Attenuated Live Vaccine Product Scope 1.2 Varicella Attenuated Live Vaccine Segment by Type 1.2.1 Global Varicella Attenuated Live Vaccine Sales by Type (2018 & 2022 & 2029) 1.2.2 Monovalent Vaccine 1.2.3 Combination Vaccine 1.3 Varicella Attenuated Live Vaccine Segment by Application 1.3.1 Global Varicella Attenuated Live Vaccine Sales Comparison by Application (2018 & 2022 & 2029) 1.3.2 Kids Injection 1.3.3 Adults Injection 1.4 Varicella Attenuated Live Vaccine Market Estimates and Forecasts (2018-2029) 1.4.1 Global Varicella Attenuated Live Vaccine Market Size in Value Growth Rate (2018-2029) 1.4.2 Global Varicella Attenuated Live Vaccine Market Size in Volume Growth Rate (2018-2029) 1.4.3 Global Varicella Attenuated Live Vaccine Price Trends (2018-2029) 2 Varicella Attenuated Live Vaccine Estimates and Forecasts by Region 2.1 Global Varicella Attenuated Live Vaccine Market Size by Region: 2018 VS 2022 VS 2029 2.2 Global Varicella Attenuated Live Vaccine Retrospective Market Scenario by Region (2018-2023) 2.2.1 Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2018-2023) 2.2.2 Global Varicella Attenuated Live Vaccine Revenue Market Share by Region (2018-2023) 2.3 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Region (2024-2029) 2.3.1 Global Varicella Attenuated Live Vaccine Sales Estimates and Forecasts by Region (2024-2029) 2.3.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Region (2024-2029) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 United States Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029) 2.4.2 Europe Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029) 2.4.3 China Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029) 2.4.4 Japan Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029) 2.4.5 Southeast Asia Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029) 2.4.6 India Varicella Attenuated Live Vaccine Estimates and Projections (2018-2029) 3 Global Varicella Attenuated Live Vaccine Competition Landscape by Players 3.1 Global Top Varicella Attenuated Live Vaccine Players by Sales (2018-2023) 3.2 Global Top Varicella Attenuated Live Vaccine Players by Revenue (2018-2023) 3.3 Global Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Varicella Attenuated Live Vaccine as of 2022) 3.4 Global Varicella Attenuated Live Vaccine Average Price by Company (2018-2023) 3.5 Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Varicella Attenuated Live Vaccine Market Size by Type 4.1 Global Varicella Attenuated Live Vaccine Historic Market Review by Type (2018-2023) 4.1.1 Global Varicella Attenuated Live Vaccine Sales by Type (2018-2023) 4.1.2 Global Varicella Attenuated Live Vaccine Revenue by Type (2018-2023) 4.1.3 Global Varicella Attenuated Live Vaccine Price by Type (2018-2023) 4.2 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Type (2024-2029) 4.2.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Type (2024-2029) 4.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Type (2024-2029) 4.2.3 Global Varicella Attenuated Live Vaccine Price Forecast by Type (2024-2029) 5 Global Varicella Attenuated Live Vaccine Market Size by Application 5.1 Global Varicella Attenuated Live Vaccine Historic Market Review by Application (2018-2023) 5.1.1 Global Varicella Attenuated Live Vaccine Sales by Application (2018-2023) 5.1.2 Global Varicella Attenuated Live Vaccine Revenue by Application (2018-2023) 5.1.3 Global Varicella Attenuated Live Vaccine Price by Application (2018-2023) 5.2 Global Varicella Attenuated Live Vaccine Market Estimates and Forecasts by Application (2024-2029) 5.2.1 Global Varicella Attenuated Live Vaccine Sales Forecast by Application (2024-2029) 5.2.2 Global Varicella Attenuated Live Vaccine Revenue Forecast by Application (2024-2029) 5.2.3 Global Varicella Attenuated Live Vaccine Price Forecast by Application (2024-2029) 6 United States Varicella Attenuated Live Vaccine Market Facts & Figures 6.1 United States Varicella Attenuated Live Vaccine Sales by Company 6.1.1 United States Varicella Attenuated Live Vaccine Sales by Company (2018-2023) 6.1.2 United States Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) 6.2 United States Varicella Attenuated Live Vaccine Sales Breakdown by Type 6.2.1 United States Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023) 6.2.2 United States Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029) 6.3 United States Varicella Attenuated Live Vaccine Sales Breakdown by Application 6.3.1 United States Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023) 6.3.2 United States Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029) 7 Europe Varicella Attenuated Live Vaccine Market Facts & Figures 7.1 Europe Varicella Attenuated Live Vaccine Sales by Company 7.1.1 Europe Varicella Attenuated Live Vaccine Sales by Company (2018-2023) 7.1.2 Europe Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) 7.2 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Type 7.2.1 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023) 7.2.2 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029) 7.3 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Application 7.3.1 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023) 7.3.2 Europe Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029) 8 China Varicella Attenuated Live Vaccine Market Facts & Figures 8.1 China Varicella Attenuated Live Vaccine Sales by Company 8.1.1 China Varicella Attenuated Live Vaccine Sales by Company (2018-2023) 8.1.2 China Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) 8.2 China Varicella Attenuated Live Vaccine Sales Breakdown by Type 8.2.1 China Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023) 8.2.2 China Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029) 8.3 China Varicella Attenuated Live Vaccine Sales Breakdown by Application 8.3.1 China Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023) 8.3.2 China Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029) 9 Japan Varicella Attenuated Live Vaccine Market Facts & Figures 9.1 Japan Varicella Attenuated Live Vaccine Sales by Company 9.1.1 Japan Varicella Attenuated Live Vaccine Sales by Company (2018-2023) 9.1.2 Japan Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) 9.2 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Type 9.2.1 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023) 9.2.2 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029) 9.3 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Application 9.3.1 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023) 9.3.2 Japan Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029) 10 Southeast Asia Varicella Attenuated Live Vaccine Market Facts & Figures 10.1 Southeast Asia Varicella Attenuated Live Vaccine Sales by Company 10.1.1 Southeast Asia Varicella Attenuated Live Vaccine Sales by Company (2018-2023) 10.1.2 Southeast Asia Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) 10.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Type 10.2.1 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023) 10.2.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029) 10.3 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Application 10.3.1 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023) 10.3.2 Southeast Asia Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029) 11 India Varicella Attenuated Live Vaccine Market Facts & Figures 11.1 India Varicella Attenuated Live Vaccine Sales by Company 11.1.1 India Varicella Attenuated Live Vaccine Sales by Company (2018-2023) 11.1.2 India Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) 11.2 India Varicella Attenuated Live Vaccine Sales Breakdown by Type 11.2.1 India Varicella Attenuated Live Vaccine Sales Breakdown by Type (2018-2023) 11.2.2 India Varicella Attenuated Live Vaccine Sales Breakdown by Type (2024-2029) 11.3 India Varicella Attenuated Live Vaccine Sales Breakdown by Application 11.3.1 India Varicella Attenuated Live Vaccine Sales Breakdown by Application (2018-2023) 11.3.2 India Varicella Attenuated Live Vaccine Sales Breakdown by Application (2024-2029) 12 Company Profiles and Key Figures in Varicella Attenuated Live Vaccine Business 12.1 Merck 12.1.1 Merck Corporation Information 12.1.2 Merck Business Overview 12.1.3 Merck Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.1.4 Merck Varicella Attenuated Live Vaccine Products Offered 12.1.5 Merck Recent Development 12.2 BCHT 12.2.1 BCHT Corporation Information 12.2.2 BCHT Business Overview 12.2.3 BCHT Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.2.4 BCHT Varicella Attenuated Live Vaccine Products Offered 12.2.5 BCHT Recent Development 12.3 Shanghai Institute 12.3.1 Shanghai Institute Corporation Information 12.3.2 Shanghai Institute Business Overview 12.3.3 Shanghai Institute Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.3.4 Shanghai Institute Varicella Attenuated Live Vaccine Products Offered 12.3.5 Shanghai Institute Recent Development 12.4 GSK 12.4.1 GSK Corporation Information 12.4.2 GSK Business Overview 12.4.3 GSK Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.4.4 GSK Varicella Attenuated Live Vaccine Products Offered 12.4.5 GSK Recent Development 12.5 Keygen 12.5.1 Keygen Corporation Information 12.5.2 Keygen Business Overview 12.5.3 Keygen Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.5.4 Keygen Varicella Attenuated Live Vaccine Products Offered 12.5.5 Keygen Recent Development 12.6 Green Cross 12.6.1 Green Cross Corporation Information 12.6.2 Green Cross Business Overview 12.6.3 Green Cross Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.6.4 Green Cross Varicella Attenuated Live Vaccine Products Offered 12.6.5 Green Cross Recent Development 12.7 Biken 12.7.1 Biken Corporation Information 12.7.2 Biken Business Overview 12.7.3 Biken Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.7.4 Biken Varicella Attenuated Live Vaccine Products Offered 12.7.5 Biken Recent Development 12.8 Shanghai Rongsheng Biotech 12.8.1 Shanghai Rongsheng Biotech Corporation Information 12.8.2 Shanghai Rongsheng Biotech Business Overview 12.8.3 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.8.4 Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Products Offered 12.8.5 Shanghai Rongsheng Biotech Recent Development 12.9 Changchun Changsheng Life Sciences Limited 12.9.1 Changchun Changsheng Life Sciences Limited Corporation Information 12.9.2 Changchun Changsheng Life Sciences Limited Business Overview 12.9.3 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Sales, Revenue and Gross Margin (2018-2023) 12.9.4 Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Products Offered 12.9.5 Changchun Changsheng Life Sciences Limited Recent Development 13 Varicella Attenuated Live Vaccine Manufacturing Cost Analysis 13.1 Varicella Attenuated Live Vaccine Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Varicella Attenuated Live Vaccine 13.4 Varicella Attenuated Live Vaccine Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Varicella Attenuated Live Vaccine Distributors List 14.3 Varicella Attenuated Live Vaccine Customers 15 Market Dynamics 15.1 Varicella Attenuated Live Vaccine Industry Trends 15.2 Varicella Attenuated Live Vaccine Market Drivers 15.3 Varicella Attenuated Live Vaccine Market Challenges 15.4 Varicella Attenuated Live Vaccine Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate by Type (2018 & 2022 & 2029) Table 2. Global Varicella Attenuated Live Vaccine Sales ((US$ Million)) Comparison by Application (2018 & 2022 & 2029) Table 3. Global Varicella Attenuated Live Vaccine Market Size (US$ Million) by Region: 2018 VS 2022 VS 2029 Table 4. Global Varicella Attenuated Live Vaccine Sales (K Doses) by Region (2018-2023) Table 5. Global Varicella Attenuated Live Vaccine Sales Market Share by Region (2018-2023) Table 6. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Market Share by Region (2018-2023)) Table 7. Global Varicella Attenuated Live Vaccine Revenue Share by Region (2018-2023) Table 8. Global Varicella Attenuated Live Vaccine Sales (K Doses) Forecast by Region (2024-2029) Table 9. Global Varicella Attenuated Live Vaccine Sales Market Share Forecast by Region (2024-2029) Table 10. Global Varicella Attenuated Live Vaccine Revenue (US$ Million) Forecast by Region (2024-2029) Table 11. Global Varicella Attenuated Live Vaccine Revenue Share Forecast by Region (2024-2029) Table 12. Global Varicella Attenuated Live Vaccine Sales by Company (K Doses) & (2018-2023) Table 13. Global Varicella Attenuated Live Vaccine Sales Share by Company (2018-2023) Table 14. Global Varicella Attenuated Live Vaccine Revenue by Company (US$ Million) & (2018-2023) Table 15. Global Varicella Attenuated Live Vaccine Revenue Share by Company (2018-2023) Table 16. Global Varicella Attenuated Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Attenuated Live Vaccine as of 2022) Table 17. Global Market Varicella Attenuated Live Vaccine Average Price by Company (USD/Dose) & (2018-2023) Table 18. Manufacturers Varicella Attenuated Live Vaccine Manufacturing Sites and Area Served Table 19. Manufacturers Varicella Attenuated Live Vaccine Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 22. Global Varicella Attenuated Live Vaccine Sales Share by Type (2018-2023) Table 23. Global Varicella Attenuated Live Vaccine Revenue by Type (2018-2023) & (US$ Million) Table 24. Global Varicella Attenuated Live Vaccine Price by Type (2018-2023) & (USD/Dose) Table 25. Global Varicella Attenuated Live Vaccine Sales by Type (2024-2029) Table 26. Global Varicella Attenuated Live Vaccine Revenue by Type (2024-2029) & (US$ Million) Table 27. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2024-2029) Table 28. Global Varicella Attenuated Live Vaccine Price by Type (2024-2029) & (USD/Dose) Table 29. Global Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 30. Global Varicella Attenuated Live Vaccine Sales Share by Application (2018-2023) Table 31. Global Varicella Attenuated Live Vaccine Revenue by Application (2018-2023) & (US$ Million) Table 32. Global Varicella Attenuated Live Vaccine Price by Application (2018-2023) & (USD/Dose) Table 33. Global Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 34. Global Varicella Attenuated Live Vaccine Sales Share by Application (2024-2029) Table 35. Global Varicella Attenuated Live Vaccine Revenue by Application (2024-2029) & (US$ Million) Table 36. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2024-2029) Table 37. Global Varicella Attenuated Live Vaccine Price by Application (2024-2029) & (USD/Dose) Table 38. United States Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses) Table 39. United States Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023) Table 40. United States Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 41. United States Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023) Table 42. United States Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 43. United States Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023) Table 44. United States Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses) Table 45. United States Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029) Table 46. United States Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 47. United States Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023) Table 48. United States Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 49. United States Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029) Table 50. Europe Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses) Table 51. Europe Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023) Table 52. Europe Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 53. Europe Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023) Table 54. Europe Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 55. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023) Table 56. Europe Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses) Table 57. Europe Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029) Table 58. Europe Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 59. Europe Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023) Table 60. Europe Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 61. Europe Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029) Table 62. China Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses) Table 63. China Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023) Table 64. China Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 65. China Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023) Table 66. China Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 67. China Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023) Table 68. China Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses) Table 69. China Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029) Table 70. China Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 71. China Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023) Table 72. China Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 73. China Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029) Table 74. Japan Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses) Table 75. Japan Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023) Table 76. Japan Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 77. Japan Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023) Table 78. Japan Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 79. Japan Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023) Table 80. Japan Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses) Table 81. Japan Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029) Table 82. Japan Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 83. Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023) Table 84. Japan Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 85. Japan Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029) Table 86. Southeast Asia Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses) Table 87. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023) Table 88. Southeast Asia Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 89. Southeast Asia Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023) Table 90. Southeast Asia Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 91. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023) Table 92. Southeast Asia Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses) Table 93. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029) Table 94. Southeast Asia Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 95. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023) Table 96. Southeast Asia Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 97. Southeast Asia Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029) Table 98. India Varicella Attenuated Live Vaccine Sales by Company (2018-2023) & (K Doses) Table 99. India Varicella Attenuated Live Vaccine Sales Market Share by Company (2018-2023) Table 100. India Varicella Attenuated Live Vaccine Revenue by Company (2018-2023) & (US$ Million) Table 101. India Varicella Attenuated Live Vaccine Revenue Market Share by Company (2018-2023) Table 102. India Varicella Attenuated Live Vaccine Sales by Type (2018-2023) & (K Doses) Table 103. India Varicella Attenuated Live Vaccine Sales Market Share by Type (2018-2023) Table 104. India Varicella Attenuated Live Vaccine Sales by Type (2024-2029) & (K Doses) Table 105. India Varicella Attenuated Live Vaccine Sales Market Share by Type (2024-2029) Table 106. India Varicella Attenuated Live Vaccine Sales by Application (2018-2023) & (K Doses) Table 107. India Varicella Attenuated Live Vaccine Sales Market Share by Application (2018-2023) Table 108. India Varicella Attenuated Live Vaccine Sales by Application (2024-2029) & (K Doses) Table 109. India Varicella Attenuated Live Vaccine Sales Market Share by Application (2024-2029) Table 110. Merck Corporation Information Table 111. Merck Description and Business Overview Table 112. Merck Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 113. Merck Varicella Attenuated Live Vaccine Product Table 114. Merck Recent Development Table 115. BCHT Corporation Information Table 116. BCHT Description and Business Overview Table 117. BCHT Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 118. BCHT Varicella Attenuated Live Vaccine Product Table 119. BCHT Recent Development Table 120. Shanghai Institute Corporation Information Table 121. Shanghai Institute Description and Business Overview Table 122. Shanghai Institute Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 123. Shanghai Institute Varicella Attenuated Live Vaccine Product Table 124. Shanghai Institute Recent Development Table 125. GSK Corporation Information Table 126. GSK Description and Business Overview Table 127. GSK Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 128. GSK Varicella Attenuated Live Vaccine Product Table 129. GSK Recent Development Table 130. Keygen Corporation Information Table 131. Keygen Description and Business Overview Table 132. Keygen Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 133. Keygen Varicella Attenuated Live Vaccine Product Table 134. Keygen Recent Development Table 135. Green Cross Corporation Information Table 136. Green Cross Description and Business Overview Table 137. Green Cross Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 138. Green Cross Varicella Attenuated Live Vaccine Product Table 139. Green Cross Recent Development Table 140. Biken Corporation Information Table 141. Biken Description and Business Overview Table 142. Biken Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 143. Biken Varicella Attenuated Live Vaccine Product Table 144. Biken Recent Development Table 145. Shanghai Rongsheng Biotech Corporation Information Table 146. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 147. Shanghai Rongsheng Biotech Description and Business Overview Table 148. Shanghai Rongsheng Biotech Varicella Attenuated Live Vaccine Product Table 149. Shanghai Rongsheng Biotech Recent Development Table 150. Changchun Changsheng Life Sciences Limited Corporation Information Table 151. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2023) Table 152. Changchun Changsheng Life Sciences Limited Description and Business Overview Table 153. Changchun Changsheng Life Sciences Limited Varicella Attenuated Live Vaccine Product Table 154. Changchun Changsheng Life Sciences Limited Recent Development Table 155. Production Base and Market Concentration Rate of Raw Material Table 156. Key Suppliers of Raw Materials Table 157. Varicella Attenuated Live Vaccine Distributors List Table 158. Varicella Attenuated Live Vaccine Customers List Table 159. Varicella Attenuated Live Vaccine Market Trends Table 160. Varicella Attenuated Live Vaccine Market Drivers Table 161. Varicella Attenuated Live Vaccine Market Challenges Table 162. Varicella Attenuated Live Vaccine Market Restraints Table 163. Research Programs/Design for This Report Table 164. Key Data Information from Secondary Sources Table 165. Key Data Information from Primary Sources List of Figures Figure 1. Varicella Attenuated Live Vaccine Product Picture Figure 2. Global Varicella Attenuated Live Vaccine Sales (US$ Million) by Type (2018 & 2022 & 2029) Figure 3. Global Varicella Attenuated Live Vaccine Sales Market Share by Type in 2022 & 2029 Figure 4. Monovalent Vaccine Product Picture Figure 5. Combination Vaccine Product Picture Figure 6. Global Varicella Attenuated Live Vaccine Sales (US$ Million) by Application (2018 & 2022 & 2029) Figure 7. Global Varicella Attenuated Live Vaccine Sales Market Share by Application in 2022 & 2029 Figure 8. Kids Injection Examples Figure 9. Adults Injection Examples Figure 10. Global Varicella Attenuated Live Vaccine Sales, (US$ Million), 2018 VS 2022 VS 2029 Figure 11. Global Varicella Attenuated Live Vaccine Sales Growth Rate (2018-2029) & (US$ Million) Figure 12. Global Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate (2018-2029) Figure 13. Global Varicella Attenuated Live Vaccine Price Trends Growth Rate (2018-2029) & (USD/Dose) Figure 14. Global Market Varicella Attenuated Live Vaccine Market Size (US$ Million) by Region:2018 VS 2022 VS 2029 Figure 15. Global Varicella Attenuated Live Vaccine Revenue Market Share by Region: 2018 VS 2022 Figure 16. United States Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029) Figure 17. United States Varicella Attenuated Live Vaccine Sales (K Doses) Growth Rate (2018-2029) Figure 18. Europe Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029) Figure 19. Europe Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029) Figure 20. China Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029) Figure 21. China Varicella Attenuated Live Vaccine Sales (US$ Million) and Growth Rate (2018-2029) Figure 22. Japan Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029) Figure 23. Japan Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029) Figure 24. Southeast Asia Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029) Figure 25. Southeast Asia Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029) Figure 26. India Varicella Attenuated Live Vaccine Revenue (US$ Million) Growth Rate (2018-2029) Figure 27. India Varicella Attenuated Live Vaccine Sales (US$ Million) Growth Rate (2018-2029) Figure 28. Global 5 Largest Varicella Attenuated Live Vaccine Players Market Share by Revenue in Varicella Attenuated Live Vaccine: 2018 & 2022 Figure 29. Varicella Attenuated Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022 Figure 30. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2018-2023) Figure 31. Global Varicella Attenuated Live Vaccine Sales Share by Type (2024-2029) Figure 32. Global Varicella Attenuated Live Vaccine Revenue Share by Type (2024-2029) Figure 33. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2018-2023) Figure 34. Global Varicella Attenuated Live Vaccine Revenue Growth Rate by Application in 2018 & 2022 Figure 35. Global Varicella Attenuated Live Vaccine Sales Share by Application (2024-2029) Figure 36. Global Varicella Attenuated Live Vaccine Revenue Share by Application (2024-2029) Figure 37. Key Raw Materials Price Trend Figure 38. Manufacturing Cost Structure of Varicella Attenuated Live Vaccine Figure 39. Manufacturing Process Analysis of Varicella Attenuated Live Vaccine Figure 40. Varicella Attenuated Live Vaccine Industrial Chain Analysis Figure 41. Channels of Distribution Figure 42. Distributors Profiles Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation Figure 45. Key Executives Interviewed

Merck BCHT Shanghai Institute GSK Keygen Green Cross Biken Shanghai Rongsheng Biotech Changchun Changsheng Life Sciences Limited